Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $311.99, but opened at $334.49. Astera Labs shares last traded at $331.49, with a volume of 1,007,863 shares changing hands.
Key Headlines Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Northland Securities substantially raised its earnings forecasts. The firm lifted its Q3 2026 EPS estimate to $0.83 from $0.47 and its FY2026 estimate to $2.75 from $1.82. It also increased its FY2027 forecast to $5.43 from $2.26, with quarterly 2027 estimates ranging from $1.13 to $1.55 per share. The revisions signal expectations for stronger AI-connectivity demand and rapid profit growth, although Northland retained a “Market Perform” rating. Northland Securities earnings estimates
- Positive Sentiment: AMD’s planned Helios AI systems ramp could benefit Astera Labs. Analysts identify ALAB as an ecosystem partner that may gain from AMD’s rack-scale AI deployments, potentially increasing demand for the company’s connectivity products. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
- Positive Sentiment: Recent operating momentum supports the bullish forecasts. Astera Labs previously reported quarterly revenue growth of 104.5% year over year, revenue above expectations, and EPS that exceeded consensus estimates.
- Neutral Sentiment: Articles comparing Astera Labs with ASE Technology and the broader computer-and-technology sector provide performance context but do not identify a new company-specific catalyst. Are Computer and Technology Stocks Lagging ASE Technology
- Negative Sentiment: Director Stefan A. Dyckerhoff sold approximately $3.9 million of ALAB shares, reducing his holdings. The transactions were executed under a pre-arranged Rule 10b5-1 plan, which lessens their significance but may still concern investors given the stock’s elevated valuation.
Analyst Upgrades and Downgrades
Several research firms have commented on ALAB. Northland Securities lowered shares of Astera Labs from an "outperform" rating to a "market perform" rating in a research note on Tuesday, May 26th. Weiss Ratings raised shares of Astera Labs from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, May 21st. Citigroup restated a "buy" rating on shares of Astera Labs in a report on Wednesday, July 29th. Needham & Company LLC lifted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Finally, Evercore reiterated an "outperform" rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and a consensus price target of $325.25.
View Our Latest Stock Analysis on ALAB
Astera Labs Trading Up 6.6%
The firm's 50-day moving average price is $359.51 and its two-hundred day moving average price is $237.55. The stock has a market cap of $57.68 billion, a PE ratio of 164.59 and a beta of 3.84.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm's quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current year.
Insider Activity at Astera Labs
In related news, General Counsel Philip Mazzara sold 14,076 shares of the company's stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28. Following the completion of the transaction, the general counsel owned 104,139 shares of the company's stock, valued at approximately $24,137,337.42. This represents a 11.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,256,894 shares of company stock valued at $362,763,135 over the last ninety days. Corporate insiders own 10.40% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the 2nd quarter worth $25,000. Johnson Financial Group Inc. purchased a new stake in shares of Astera Labs during the second quarter worth about $43,000. Bell Investment Advisors Inc purchased a new position in Astera Labs in the 2nd quarter valued at about $43,000. Reflection Asset Management purchased a new position in Astera Labs in the 4th quarter valued at about $25,000. Finally, Trifecta Capital Advisors LLC acquired a new stake in Astera Labs in the 2nd quarter worth about $79,000. 60.47% of the stock is owned by institutional investors and hedge funds.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.